Showing results (11-20 of 1,071) with videos related to

Sort By:
Pageof 108
Experimental Parasitology|March 7, 2017
Integrating genomics and proteomics permits identification of immunodominant antigens associated with drug resistance in human visceral leishmaniasis in IndiaNeeloo Singh, Shyam Sundar
Plos One|June 29, 2018
Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasisNeetu Singh, Shyam Sundar
International Journal of Environmental Research and Public Health|February 15, 2011
Antimony toxicityShyam Sundar, Jaya Chakravarty
Expert Review of Vaccines|March 11, 2014
Identifying vaccine targets for anti-leishmanial vaccine developmentShyam Sundar, Bhawana Singh
Vaccine|April 6, 2012
Leishmaniasis: vaccine candidates and perspectivesBhawana Singh, Shyam Sundar
Journal of Global Infectious Diseases|July 8, 2010
Drug resistance in leishmaniasisJaya Chakravarty, Shyam Sundar
Therapeutic Advances in Infectious Disease|August 19, 2016
Recent developments and future prospects in the treatment of visceral leishmaniasisShyam Sundar, Anup Singh
Expert Opinion on Pharmacotherapy|December 22, 2012
Leishmaniasis: an update of current pharmacotherapyShyam Sundar, Jaya Chakravarty
The Pediatric Infectious Disease Journal|December 28, 2017
Visceral Leishmaniasis-Optimum Treatment Options in ChildrenShyam Sundar, Dipti Agarwal
Expert Opinion on Investigational Drugs|November 21, 2014
Investigational drugs for visceral leishmaniasisShyam Sundar, Jaya Chakravarty
Pageof 108